NT
Nutriband Inc.
NTRBW · NASDAQ
$1.57 -39.85% (-$1.04)
1M +311.43%
Market Cap $18.7M
P/E Ratio -
Div. Yield -
ROE 109.02%
Bulios Fair Price
$0.94
40.1% downside
Current Price
$1.57
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NTRBW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
29 /100
Expensive P/S 11.59x
P/B 3.52x
P/E N/A
Growth
13 /100
Declining Rev. growth 0.69%
Book val. growth 7.98%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 33.14%
Net margin 430.43%
Op. margin 435.58%
Quality
3 /100
Poor ROIC 127.00%
ROE 109.02%
ROA 110.64%
Debt
69 /100
Low Debt/Equity 0.04x
Current ratio 4.21x
Int. coverage -550.70x
Stability
33 /100
Unstable Beta 1.97x
Rev. volatility 3.81%
EPS volatility 74.94%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NTRBW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gareth Sheridan
Employees
3
Headquarters
Orlando
Upcoming events
30 SEP
Earnings
Upcoming earnings report
07 DEC
Earnings
Upcoming earnings report